Skip to main content
Clinical Trials/KCT0007043
KCT0007043
Recruiting
未知

A 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of SGF500 on dry eye

Jeonbuk National University Hospital0 sites80 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the eye and adnexa
Sponsor
Jeonbuk National University Hospital
Enrollment
80
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) OSDI \=13 at screening test
  • 2\) TBUT\=10 or (\+) on Fluorescein staining at screening test
  • 3\) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions

Exclusion Criteria

  • 1\) Patients with a clinically significant disease requiring treatment (i.e., cardiovascular system, endocrine system, immune system, respiratory system, hepatobiliary system, kidney and urinary system, neuropsychiatric system, musculoskeletal inflammation, inflammatory disease, blood and tumor disease, gastrointestinal disease, etc.)
  • 2\) Patients with a history of antipsychotic medication use within 3 months prior to the screening examination
  • 3\)Patients who have participated in other clinical trials within 3 months prior to the screening examination
  • 4\)Patients who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes

Outcomes

Primary Outcomes

Not specified

Similar Trials